Wooridul Huebrain Limited

KSE 118000.KS

Wooridul Huebrain Limited EBITDA Margin for the year ending December 31, 2023: -37.45%

Wooridul Huebrain Limited EBITDA Margin is -37.45% for the year ending December 31, 2023, a 74.16% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Wooridul Huebrain Limited EBITDA Margin for the year ending December 31, 2022 was -144.93%, a -246.72% change year over year.
Wooridul Huebrain Limited EBITDA Margin for the year ending December 31, 2021 was 98.78%, a 88.71% change year over year.
Wooridul Huebrain Limited EBITDA Margin for the year ending December 31, 2020 was 52.35%, a 2,299.16% change year over year.
Wooridul Huebrain Limited EBITDA Margin for the year ending December 31, 2019 was 2.18%, a 107.88% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

KSE: 118000.KS

Wooridul Huebrain Limited

CEO	Ms. Soo-Kyung Kim
IPO Date	May 5, 2006
Location	South Korea
Headquarters	156, No. 202, Dream Building)
Employees	23
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Cosmetics Dental Care Hardware & Electronics Medical Instruments Personal Care Pharmaceuticals

Description

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014. Wooridul Huebrain Limited was founded in 2009 and is based in Seoul, South Korea.

Key trends

Past 5 years